✦ LIBER ✦

The hedgehog pathway as a therapeutic target for treatment of breast cancer

✍ Scribed by M. F. Barginear; M. Leung; D. R. Budman

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 276 KB
Volume: 116
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-009-0423-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hedgehog signaling pathway is a possible

Hedgehog signaling pathway is a possible therapeutic target for gastric cancer

✍ Kosuke Yanai; Shuntaro Nagai; Junji Wada; Naoki Yamanaka; Masafumi Nakamura; Nob 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

## Abstract ## Background and Objectives It has been shown that the hedgehog (Hh) signaling pathway is activated in gastric cancer. To investigate the viability of the Hh pathway as a therapeutic target, we analyzed activation of the Hh pathway in gastric cancer. ## Methods Surgically resected g

Small-Molecule Inhibitors of the Hedgeho

Small-Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics

✍ Stefan Peukert; Karen Miller-Moslin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Nerve growth factor/nuclear factor-κB pa

Nerve growth factor/nuclear factor-κB pathway as a therapeutic target in breast cancer

✍ Ali Naderi; Luke Hughes-Davies 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 516 KB

The wnt/β-catenin signaling pathway: A p

The wnt/β-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer

✍ Taj D. King; Mark J. Suto; Yonghe Li 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

ChemInform Abstract: Small-Molecule Inhi

ChemInform Abstract: Small-Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics

✍ Stefan Peukert; Karen Miller-Moslin 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 15 KB 👁 1 views

Wnt/β-catenin-pathway as a molecular tar

Wnt/β-catenin-pathway as a molecular target for future anti-cancer therapeutics

✍ Susanne Dihlmann; Magnus von Knebel Doeberitz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 213 KB

Conventional chemotherapeutic drugs used for the treatment of cancer patients in advanced stages have yielded only limited benefit, regarding survival time not to mention cure of the patients. To improve the clinical outcome of cancer, agents aimed at novel molecular targets are required. Colorectal